Atomoxetine, a medication used to treat attention-deficit/hyperactivity disorder (ADHD), is manufactured by several pharmaceutical companies. The active ingredient, atomoxetine hydrochloride, is available in generic forms from multiple producers.
Who makes generic atomoxetine?
Companies that manufacture generic versions of atomoxetine include Teva Pharmaceuticals, Mylan N.V. (now Viatris), and Apotex. These companies produce the drug under their own brand names or as unbranded generics.
When does atomoxetine patent exclusivity end?
Patent exclusivity for brand-name atomoxetine, originally marketed as Strattera by Eli Lilly and Company, has expired. This expiration allows for the production and sale of generic alternatives. Details on specific patent expiry dates for pharmaceutical products can be found on resources like DrugPatentWatch.com [1].
What are the brand names for atomoxetine?
The primary brand name for atomoxetine in the United States was Strattera [2]. However, as generic versions have become available, atomoxetine is also sold under various generic labels.
How does atomoxetine work?
Atomoxetine is a selective norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of norepinephrine, a neurotransmitter, in certain parts of the brain. This action is believed to help improve focus and attention in individuals with ADHD [3].
What are the side effects of atomoxetine?
Common side effects associated with atomoxetine can include upset stomach, nausea, vomiting, fatigue, decreased appetite, dizziness, and mood swings. More serious, though less common, side effects may involve liver problems, cardiovascular issues, and suicidal thoughts or behavior, particularly in children and adolescents [3].
What is atomoxetine used to treat?
Atomoxetine is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults [2]. It is typically used as a non-stimulant alternative for managing ADHD symptoms.
Can atomoxetine be used during pregnancy?
The use of atomoxetine during pregnancy should be carefully considered. Information regarding its safety and potential risks to a developing fetus is available, and healthcare providers weigh these factors when making treatment decisions [3].
How does atomoxetine compare to stimulant ADHD medications?
Atomoxetine is a non-stimulant medication, distinguishing it from stimulant drugs like methylphenidate (Ritalin) and amphetamines (Adderall). While stimulants directly increase dopamine and norepinephrine levels, atomoxetine primarily targets norepinephrine. This difference in mechanism can lead to variations in effectiveness, side effect profiles, and onset of action among individuals [3].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.webmd.com/drugs/2/200074/atomoxetine-oral/details
[3] https://www.nhs.uk/medicines/atomoxetine/